🔗 Share this article

The Nobel Prize in medical science was awarded for transformative findings that illuminate how the immune system targets harmful infections while protecting the healthy tissues.

Three esteemed researchers—Japan's Shimon Sakaguchi and American experts Dr. Brunkow and Fred Ramsdell—share this accolade.

The work uncovered specialized "sentinels" within the immune system that eliminate malfunctioning defense cells that could harming the organism.

These findings are now paving the way for new therapies for immune disorders and malignancies.

The laureates will divide a monetary award worth 11m Swedish kronor.

Crucial Discoveries

"The research has been decisive for comprehending how the body's defenses functions and the reason we don't all develop serious self-attack conditions," commented the chair of the Nobel Committee.

The trio's research address a core question: How does the immune system defend us from countless invaders while leaving our healthy cells intact?

The body's protection system uses white blood cells that search for indicators of infection, even viruses and germs it has not met before.

These defenders employ sensors—known as receptors—that are produced by chance in a vast number of variations.

This provides the defense network the capacity to fight a broad range of invaders, but the unpredictability of the mechanism unavoidably creates immune cells that may target the body.

Security Guards of the Body

Researchers previously understood that some of these harmful white blood cells were eliminated in the immune organ—where immune cells mature.

The latest award honors the discovery of T-reg cells—known as the immune system's "peacekeepers"—which patrol the body to neutralize any immune cells that assault the body's own tissues.

We know that this mechanism malfunctions in self-attack conditions such as juvenile diabetes, multiple sclerosis, and RA.

A Nobel panel added, "These findings have established a new field of investigation and accelerated the development of new treatments, for example for tumors and immune disorders."

Regarding cancer, T-regs block the body from attacking the growth, so research are focused on reducing their numbers.

For self-attack disorders, experiments are exploring increasing T-reg cells so the organism is no longer being harmed. A comparable approach could also be useful in reducing the risks of transplanted organ failure.

Pioneering Studies

Prof Shimon Sakaguchi, from a Japanese institution, performed tests on mice that had their thymus removed, leading to self-attack conditions.

The researcher showed that introducing immune cells from other mice could stop the disease—implying there was a mechanism for preventing defenders from harming the body.

Dr. Brunkow, from the Institute for Systems Biology in Seattle, and Fred Ramsdell, now at a biotech firm in San Francisco, were studying an inherited autoimmune disease in rodents and people that led to the identification of a gene critical for the way T-regs function.

"The groundbreaking work has uncovered how the body's defenses is kept in check by regulatory T cells, stopping it from mistakenly targeting the body's own tissues," commented a prominent biological science specialist.

"This research is a remarkable illustration of how basic physiological study can have far-reaching implications for public health."